Muhib Khan

Prof. Muhib Khan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Clinical Parkinsonism & Related Disorders
Verified
Journal Article
Open access
HMHeather Martin
Heather Martin
RARushna Ali
Rushna Ali
ASAshok Sriram
Ashok Sriram
RCRobert Coleman
Robert Coleman
EREmily Ruether
Emily Ruether
MKMuhib Khan
Muhib Khan
We sought to assess the impact of leukoaraiosis (LA) on motor outcomes in Parkinson disease (PD) patients undergoing DBS. We hypothesized that LA is associated with less improvement in motor function in PD patients post-DBS. We reviewed data of adult patients with PD treated with DBS in a single center between 2012 and 2021. Demographics, risk factors, medications, Hoehn and Yahr scale and Unified Parkinson’s Disease Rating Scale (UPDRS) Motor Score before and after DBS and severity of LA were collected. Simple linear regression (SLR) was used to determine variables of interest to include in the multiple linear regression (MLR). MLR was used to determine independent predictors of motor outcomes (UPDRS) post-DBS including LA as a continuous and dichotomized variable of interest. A total of 90 patients were included in the analysis. Mean age was 65.7 years (±9.7), primarily male (69 %) with a high incidence of young onset PD (29 %), treated with carbidopa/levodopa combination (98 %) and with moderate severity of disease (Hoehn and Yahr Stage 2.0 [2.0, 2.5]). Moderate to severe leukoaraiosis was noted in 26 (32.5 %) patients. SLR revealed age, diabetes and disease severity as predictors of post-DBS motor UPDRS. In adjusted analysis, LA was not an independent predictor of motor outcomes post-DBS either as continuous (β = 0.20, p = 0.77) or dichotomized (β = −0.64; p = 0.77) variable. In conclusion, our data suggests that motor outcomes in Parkinson’s disease patients undergoing deep brain stimulation (DBS) are not impacted by pre-existing leukoaraiosis. Further studies are needed to validate our findings.

22 December 2025 in Medicina
Verified
Journal Article
Open access
PDF file
ALAnna Liu
Anna Liu
HXHelena Xeros
Helena Xeros
WWWaseem Wahood
Waseem Wahood
ZKZafer Keser
Zafer Keser
MKMuhib Khan
Muhib Khan
Background and Objectives: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by multisystem involvement, including renal cysts, hepatic cysts, intracranial aneurysms, and aortic root dilatation and dissection. Though exceedingly rare, cervical artery dissections (CeAD) have been reported in association with ADPKD. The aim of this retrospective observational study is to investigate clinical features in patients with ADPKD that increase the probability of an associated CeAD diagnosis. Materials and Methods: The National Inpatient Sample from 2016 to 2020 was utilized to compare clinical features for patients with an ICD-10 code diagnosis of ADPKD, CeAD, and both ADPKD and CeAD. The Cochran–Armitage test and Chi-square test were utilized to assess clinical features or trends in ADPKD patients associated with a concurrent CeAD diagnosis. Results: Between 2016 and 2020, there were 224,065 people with ADPKD, 86,135 with CeAD and 155 with both (0.05%). The total cohort had a mean age of 56.74 years, with 47.26% female participants (p = 0.70), and was predominantly white (66.15%, p < 0.001). In patients with ADPKD, comorbid acute ischemic stroke (p < 0.001), transient ischemic attack (p < 0.001), aortic dissection (p < 0.001), coronary artery dissection (p < 0.001), subarachnoid hemorrhage (p < 0.001), coagulation defects (p = 0.002), and hypertension (p < 0.001) are risk factors associated with an increased probability of concomitant CeAD. Conclusions: CeAD in ADPKD patients is rare. In ADPKD patients, acute ischemic stroke, transient ischemic attack, aortic dissection, coronary artery dissection, subarachnoid hemorrhage, coagulation defects, and hypertension are risk factors of concomitant CeAD. Recognizing these factors can aid in the decision to screen for concomitant CeAD in patients with ADPKD.

2 April 2026 in Contemporary Neurosurgery
Verified
Journal Article
Closed access
IKInamullah Khan
Inamullah Khan
KNKaavya Nair
Kaavya Nair
MKMuhib Khan
Muhib Khan
RARushna Ali
Rushna Ali
DEDmitry Do Esterov
Dmitry Do Esterov
ZKZafer Keser
Zafer Keser
Noninvasive brain stimulation (NIBS) techniques, including transcranial magnetic stimulation (TMS), transcranial direct and alternating current stimulation (tDCS, tACS), and transcutaneous vagus nerve stimulation (tVNS), represent promising tools for neurorehabilitation and symptom management across neurological and psychiatric conditions. These modalities modulate cortical excitability, foster neuroplasticity, and target maladaptive network activity. Evidence supports applications in stroke, Parkinson disease (PD), Alzheimer disease, chronic pain, and psychiatric disorders, though methodological variability, heterogeneous patient populations, and lack of standardization limit clinical translation. This review synthesizes current knowledge, highlights therapeutic potential, and underscores the need for rigorous trials to establish efficacy and optimize treatment protocols.